RXRX Recursion Pharmaceuticals
Price Chart
Executive Summary
Recursion Pharmaceuticals granted inducement RSU awards covering ~2.99 million shares to 33 new employees under its 2024 Inducement Equity Incentive Plan, as a material inducement to their employment. The awards vest over four years with a one-year cliff. This is a routine equity grant for new hires and does not reflect any change in business operations or financial performance.
Actionable Insight
Routine inducement grants for new hires — no material impact on stock. Monitor for any future insider selling patterns or changes in employee retention, but this filing alone does not warrant trading action.
Key Facts
- Inducement RSU awards covering 2,991,840 shares granted to 33 new employees.
- Awards vest 1/4th on first quarterly vesting date after one-year anniversary, then 1/16th quarterly thereafter.
- Grants made under the 2024 Inducement Equity Incentive Plan per Nasdaq Listing Rule 5635(c)(4).
- No financial terms or performance metrics disclosed; standard new-hire equity compensation.
Financial Impact
~2.99 million shares granted, representing approximately 0.9% of outstanding shares (based on ~330M shares outstanding per market cap of $1.8B at ~$5.45/share). No cash consideration.
Risk Factors
- Potential dilution of ~0.9% over vesting schedule, but immaterial in near term.
- No performance conditions — awards are time-based, so retention risk if stock declines.
Market Snapshot
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3303818 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 5, 2026
1d ago
|
Insider Cluster
| $3.32 awaiting T+1 | awaiting T+1 | — | $3.32 (+0.00%) |
|
May 29, 2026
8d ago
|
Press Release
| $3.79 $3.61 | ▼ −4.75% | ▼ −4.90% | $3.32 (−12.53%) |
|
May 6, 2026
4w ago
|
Press Release
| $3.43 $3.27 | ▼ −4.66% | ▼ −4.33% | $3.32 (−3.35%) |
|
May 5, 2026
4w ago
|
Insider Cluster
| $3.37 $3.43 | ▲ +1.78% | ▲ +0.40% | $3.32 (−1.63%) |
|
Apr 7, 2026
8w ago
|
Insider Cluster
| $3.19 $3.39 | ▲ +6.27% | ▲ +3.73% | $3.32 (+3.92%) |
|
Mar 25, 2026
10w ago
|
Press Release
| $3.17 $3.15 | ▼ −0.63% | ▲ +1.14% | $3.32 (+4.57%) |
|
Mar 17, 2026
11w ago
|
Insider Cluster
| $3.42 $3.32 | ▼ −2.92% | ▼ −1.53% | $3.32 (−3.07%) |
|
Feb 25, 2026
14w ago
|
8-K
| $3.77 $3.77 | · 0.00% | ▲ +0.55% | $3.32 (−12.07%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access